MediWound Ltd. (MDWD) NASDAQ

Currency In USD

AD

MediWound Ltd.

Address

42 Hayarkon Street

Yavne, HM 8122745

Israel

Phone

972 7 797 14100

Sector

Healthcare

Industry

Biotechnology

Employees

121

First IPO Date

March 20, 2014

Key Executives

NameTitlePayYear Born
Ofer GonenChief Executive Officer834,0001973
Yaron Meyer Adv.Executive Vice President, General Counsel & Corporate Secretary337,0001979
Hani LuxenburgChief Financial Officer420,0001974
Shmulik HessChief Operating Officer & Chief Commercial Officer426,0001974
Ety KlingerChief Medical Officer428,0001962
Liron GalVice President of Manufacturing Science & Technology0N/A
Robert J. Snyder FFPMSenior Vice President of Global Medical Affairs01951
Hagit MashiachVice President of Human Resources0N/A
Barry J. WolfensonExecutive Vice President of Strategy & Corporate Development01967
AD

Description

MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.

AD